Renal sodium handling in cyclosporine a (CSA) treated liver transplant (LT) recipients.

被引：0
|
作者：
Canzanello, VJ [1 ]
Textor, SC [1 ]
Taler, SJ [1 ]
Schwartz, L [1 ]
Porayko, MK [1 ]
Wiesner, RH [1 ]
Krom, RA [1 ]
机构：
[1] MAYO CLIN, ROCHESTER, MN USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1996年 / 7卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：A1489 / A1489
页数：1
相关论文
共 50 条
  • [1] Steroid withdrawal in Cyclosporin A (CsA)-treated liver transplant (LT) recipients. Pathological and biochemical assessment
    Brigot, C
    Duvoux, C
    Pageaux, G
    Zafrani, ES
    Coste, V
    Bismuth, M
    Roudot-Thoraval, F
    Cherqui, D
    Domergue, J
    Larrey, D
    Dhumeaux, D
    JOURNAL OF HEPATOLOGY, 2000, 32 : 54 - 54
  • [2] Measurement of renal function in liver transplant (LT) recipients.
    Te, HS
    Cronin, DC
    Wherity, K
    Hodge, E
    Baker, AL
    HEPATOLOGY, 2002, 36 (04) : 670A - 670A
  • [3] Steroid withdrawal in cyclosporin A (CsA)-treated liver transplant (LT) recipients. Pathological and biochemical assessment.
    Brigot, C
    Duvoux, C
    Pageaux, G
    Zafrani, ES
    Coste, V
    Bismuth, M
    Roudot-Thoraval, F
    Larrey, D
    Dhumeaux, D
    HEPATOLOGY, 2000, 32 (04) : 597A - 597A
  • [4] Conversion of cyclosporine (neoral;: CsA) to mycophenolate mofetil (MMF) in stable renal transplant recipients.
    Schrama, YC
    Hené, RJ
    Boer, P
    Koomans, HA
    KIDNEY INTERNATIONAL, 1999, 55 (04) : 1625 - 1626
  • [5] Screening for hypomagnesemia in cyclosporine or FK 506 treated renal transplant recipients.
    Gupta, BK
    Glicklich, D
    TRANSPLANTATION, 1999, 67 (07) : S152 - S152
  • [6] EFFECT OF FELODIPINE ON RENAL HEMODYNAMICS AND TUBULAR SODIUM HANDLING IN CYCLOSPORINE-TREATED RENAL-TRANSPLANT RECIPIENTS
    SORENSEN, SS
    SKOVBON, H
    EISKJAER, H
    THOMSEN, K
    PEDERSEN, EB
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (01) : 69 - 78
  • [7] Analysis of cyclosporine associated arteriolopathy in long-term cyclosporine treated renal transplant recipients.
    Ishii, D
    Tanabe, K
    Ishida, H
    Miyamoto, N
    Ishikawa, N
    Tokumoto, T
    Shirakawa, H
    Shimizu, T
    Shimmura, H
    Setoguchi, K
    Toki, D
    Toma, H
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 555 - 555
  • [8] National transplantation pregnancy registry: Outcomes of pregnancies in female cyclosporine treated (CsA) renal recipients.
    Armenti, VT
    Gaughan, WJ
    Cater, JR
    Smith, JA
    McGrory, CH
    Radomski, JS
    Moritz, MJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3275 - A3275
  • [9] Effect of conversion from cyclosporine A (CSA) to tacrolimus (FK 506) on cardiovascular risk factors in liver transplant recipients.
    Canzanello, VJ
    Schwartz, LL
    Taler, SJ
    Textor, SC
    Atwood, G
    Porayko, MK
    Wiesner, RH
    Krom, RAF
    HEPATOLOGY, 1997, 26 (04) : 1443 - 1443
  • [10] LONG-TERM ANALYSIS OF RENAL-FUNCTION IN LIVER-TRANSPLANT RECIPIENTS (OLTR) TREATED WITH CYCLOSPORINE-A (CSA)
    MALE, R
    CAREY, WD
    VOGT, D
    BROUGHAN, TA
    HEPATOLOGY, 1992, 16 (04) : A283 - A283
12345